PRKD3 and breast carcinoma: Even though it is not known whether this mechanism also occurs in breast cancer cells, both observations together could indicate that PKD1 silencing and PKD3 overexpression, through different mechanisms, mutually converge in the activation of the mTORC1-S6K axis.